February 22, 2017 / 12:09 PM / 5 months ago

BRIEF-Lannett Co says FDA agreed to delay submission deadline for Methylphenidate ER tablets

1 Min Read

Feb 22 (Reuters) - Lannett Company Inc

* Lannett provides further update on methylphenidate er tablets

* Lannett company inc- FDA agreed to delay submission deadline for Methylphenidate ER tablets

* Lannett company-FDA suspended deadline to submit materials in support of its request for hearing to consider FDA's proposal co withdraw ANDA for Methylphenidate ER

* Lannett co-FDA expected to discuss sufficiency of documents related to Methylphenidate ER tablets with co once documents are released

* Lannett co-FDA expected to establish new dates for submission of materials in support of hearing request Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below